The analyst rating is based on the performance of Chinese insurers in the first quarter, where CHINA LIFE reported a significant decline in net profit due to its aggressive investment strategy, while NCI showed an unexpected profit increase. PING AN and CPIC demonstrated stable results with balanced investment strategies. The broker believes that the market has already accounted for weak profit factors, and investors will shift focus to market developments and long-term growth. PING AN and CHINA LIFE are highlighted as top picks, with both rated as 'Buy'.
